Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,981-7,992 of 10,612

Behavioral study icon

CompletedNCT04843046

Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: Addiction

Drug study icon

TerminatedNCT01395797

Pioglitazone for Heroin and for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 55 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Behavioral study icon

CompletedNCT03864146

Pioglitazone for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Addiction

Behavioral study icon

CompletedNCT00835120

Pioglitazone for Bipolarity and Comorbid Metabolic Syndrome or Insulin Resistance

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: Bipolarity, Depression

Drug study icon

TerminatedNCT01717040

Pioglitazone for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugOver 18 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00000198

Piracetam for Treatment of Cocaine Addiction - 3

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

WithdrawnNCT00000199

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrug

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

TerminatedNCT04596267

Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 55 Years

Countries: United States
Sponsor: Boston Medical Center
Condition: Addiction

Drug study icon

CompletedNCT00141505

PK Effects of Bifeprunox & Valproate in Bipolar I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Solvay Pharmaceuticals
Condition: Bipolarity

Drug study icon

CompletedNCT02687984

PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indivior Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT02536105

PK/PD Pediatric ADHD Classroom Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 12 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Drug study icon

CompletedNCT00221403

Placebo Controlled study of Valproate and Risperidone in Young Children With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 3 Years to 7 Years

Countries: United States
Sponsor: Children's Hospital Medical Center, Cincinnati
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.